A burgeoning family of biological mediators: Chemokines and chemokine receptors

Archivum Immunologiae et Therapiae Experimentalis

Volumn 48, Issue 3, 2000, Pages 143-150

  Le, Yingying ^a   Gong, Wanghua ^a   Shen, Weiping ^a   Li, Bacqun ^a   Dunlop, Nancy M ^a   Wang, Ji Ming ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Chemokines; G protein coupled receptor; Leukocytes

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN;

ANIMAL; CHEMISTRY; HUMAN; IMMUNOLOGY; IMMUNOPATHOLOGY; INFLAMMATION; LEUKOCYTE; METABOLISM; REVIEW;

ANIMALS; CHEMOKINES; GTP-BINDING PROTEINS; HUMANS; IMMUNE SYSTEM DISEASES; INFLAMMATION; LEUKOCYTES; RECEPTORS, CHEMOKINE;

EID: 0033642540     PISSN: 0004069X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (71)

1. AMARA A., GALL S. L., SCHWARTZ O., SALAMERO J., MONTES M., LOETSCHER P., BAGGIOLINI M., VIRELIZIER J. L. and ARENZANA-SEISDEDOS F. (1997): HIV coreceptor downregulation as antiviral principle: SDF1 α-dependent internalization of the chemokine receptor CXCR4 contributes to inhibition of HIV replication. J. Exp. Med., 186, 139-146.
2. ARVANITAKIS L., GERAS-RAAKA E., VARMA A., GERSHENGORN M. C. and CESARMAN E. (1997): Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation. Nature, 385, 347-349.
3. BAGGIOLINI M., DEWARD B. and MOSER B. (1994): Interleukin-8 and related chemotactic cytokines-CXC and CC chemokines. Adv. Immunol., 55, 97-179.
4. BAGGIOLINI M., DEWARD B. and MOSER B. (1997): Human chemokines: an update. Annu. Rev. Immunol., 5, 675-705.
5. BALKWILL F. (1998): The molecular and cellular biology of the chemokines. J. Virol. Hepatitis, 5, 1-14.
6. BAZAN J. F., BACON K. B., HARDIMAN G., WANG W., SOO K., ROSSI D., GREAVES D. R., ZLOTNIK A. and SCHALL T. J. (1997): A new class of membrane-bound chemokine with CX3C motif. Nature, 385, 640-644.
7. BEN-BARUCH A., MICHIEL D. F. and OPPENHEIM J. J. (1995): Signals and receptors involved in recruitment of inflammatory cells. J. Biol. Chem., 270, 11703-11706.
8. BROXMEYER H. E., COOPER S., HAGUE N., BENNINGER L., SARRIS A., CORNETTA K., VADHAN RAJ S., HENDRIE P. and MANTEL C. (1995): Human chemokines: enhancement of specific activity and effects in vitro on normal and leukemic progenitors and a factor-dependent cell line and in vivo in mice. Ann. Hematol., 71, 235-246.
9. CHITNIS C. E., CHAUDHURI A., HORUK R., POGO A. O. and MILLER L. H. (1996): The domain on the Duffy blood group antigen for binding Plasmodium vivax and P. knowlesi malaria parasites to erythrocytes. J. Exp. Med., 184, 1531-1536.
10. CHUNG C. W., COOKE R. M., PROUDFOOT A. E. and WELLS T. N. (1995): The three-dimensional solution structure of RANTES. Biochemistry, 34, 9307-9314.
11. CLARK-LEWIS I., DEWALD B., GEISER T., MOSER B. and BAGGIOLINI M. (1993): Platelet factor 4 binds to interleukin 8 receptors and activates neutrophils when its N terminus is modified with Glu-Leu-Arg. Proc. Natl. Acad. Sci. USA, 90, 3574-3577.
12. CLARK-LEWIS I., SCHUMACHER C., BAGGIOLINI M. and MOSER B. (1991): Structure-activity relationships of interleukin-8 determined using chemically synthesized analogs: critical role of NH2-terminal residues and evidence for uncoupling of neutrophil chemotaxis, exocytosis, and receptor binding activities. J. Biol. Chem., 266, 23128-23134.
13. CLORE G. M., APPELLA E., YAMADA M., MATSUSHIMA K. and GRONENBORN A. M. (1990): Three-dimensional structure of interleukin 8 in solution. Biochemistry, 29, 1689-1696.
14. + T cells. Science, 70, 1811-1815.
15. COOK D. N., BECK M. A., COFFMAN T. M., KIRBY S. L., SHERIDAN J. F., PRAGNELL I. B. and SMITHIES O. (1995): Requirement of MIP-1 alpha for an inflammatory response to viral infection. Science, 269, 1583-1585.
16. DEAN M., CARRINGTON M., WINKLER C., HUTTLEY G. A., SMITH M. W., ALLIKMETS R., GOEDERT J. J., BUCHBINDER S. P., VITTINGHOFF E., GOMPERTS E., DONFIELD S., VLAHOV D., KASLOW R., SAAH A., RINALDO C., DETELS R. and O'BRIEN S. (1996): Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science, 273, 1856-1862.
17. GAO J. L., WYNN T. A., CHANG Y., LEE E. J., BROXMEYER H. E., COOPER S., TIFFANY H. L., WESTPHAL H., KWON-CHUNG J. and MURPHY P. M. (1997): Impaired host defense, hematopoiesis, granulomatous inflammation and type 1 -type 2 cytokine balance in mice lacking CC chemokine receptor 1. J. Exp. Med., 185, 1959-1968.
18. GERARD C., FROSSARD J. L., BHATIA M., SALUJA A., GERARD N. P., LU B. and STEER M. (1997): Targeted disruption of the beta-chemokine receptor CCR1 protects against pancreatitis-associated lung injury. J. Clin. Invest., 100, 2022-2027.
19. GONG J. H. and CLARK-LEWIS I. (1995): Antagonists of monocyte chemoattractant protein 1 identified by modification of functionally critical NH2-terminal residues. J. Exp. Med., 181, 631-640.
20. GONG W., HOWARD O. M. Z., TURPIN J. A., GRIMM M. C., UEDA H., GRAY P. W., RAPORT C. J., OPPENHEIM J. J. and WANG J. M. (1998): Monocyte chemotactic protein (MCP)-2 activates CCR5 and blocks CD4/CCR5-mediated HIV-1 fusion/replication. J. Biol. Chem., 273, 4289-4292.
21. GUO H. G., BROWNING P., NICHOLAS J., HAYWARD G. S., TSCHACHLER E., JIANG Y. W., SADOWSKA M., RAFFELD M., COLOMBINI S., GALLO R. C. and REITZ M. S. JR. (1997): Characterization of a chemokine receptor-related gene in human herpesvirus 8 and its expression in Kaposi's sarcoma. Virology, 228, 371-378.
22. HAMMOND M. E., SHYAMALA V., SIANI M. A., GALLEGOS C. A., FEUCHT P. H., ABBOTT J., LAPOINTE G. R., MOGHADAM M., KHOJA H., ZAKEL J. and TEKAMP-OLSON P. (1996): Receptor recognition and specificity of interleukin-8 is determined by residues that cluster near a surface-accessible hydrophobic pocket. J. Biol. Chem., 271, 8228-8235.
23. HANDEL T. M. and DOMAILLE P. J. (1996): Heteronuclear (1H, 13C, 15N) NMR assignments and solution structure of the monocyte chemoattractant protein-1 (MCP-1) dimer. Biochemistry, 35, 6569-6584.
24. HARADA A., SEKIDO N., AKAHOSHI T., WADA T., MUKAIDA N. and MATSUSHIMA K. (1994): Essential involvement of interleukin-8 (IL-8) in acute inflammation. J. Leukoc. Biol., 56, 559-564.
25. HEBERT C. A., VIYTANGCOL R. V. and BAKER J. B. (1991): Scanning mutagenesis of interleukin-8 identifies a cluster of residues required for receptor binding. J. Biol. Chem., 266, 18989-18994.
26. HORUK R. (1999): Chemokine receptors and HIV-1: the fusion of two major research fields. Immunol. Today, 2, 89-94.
27. HORUK R., HESSELGESSER J., ZHOU Y., FAULDS D., HALKS-MILLER M., HARVEY S., TAUB D., SAMSON M., PARMENTIER M., RUCKER J., DORANZ B. J. and DOMS R. W. (1998): The CC chemokine I 309 inhibits CCR8-dependent infection by diverse HIV-1 strains. J. Biol. Chem., 273, 386-391.
28. HORUK R., MARTIN A., HESSELGESSER J., HADLEY T., LU Z. H., WANG Z. X. and PEIPER S. C. (1996): The Duffy antigen receptor for chemokine: structural analysis and expression in the brain. J. Leukoc. Biol., 59, 29-38.
29. HOWARD O. M. Z., OPPENHEIM J. J. and WANG J. M. (1999): Chemokines as molecular targets for therapeutic intervention. J. Clin. Immunol., 19, 280-292.
30. IMAI T., HIESHIMA K., HASKELL C., BABA M., NAGIRA M., NISHIMURA M., KAKIZAKI M., TAKAGI S., NOMIYAMA H., SCHALL T. J. and YOSHIE O. (1997): Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell, 91, 521-530.
31. KELNER G. S., KENNEDY J., BACON K. B., KLEYENSTEUBER S., LARGAESPADA D. A., JENKINS N. A., COPELAND N. G., BAZAN J. F., MOORI K. W., SCHALL T. J. and ZLONIK A. (1994): Lymphotactin: a cytokine that represents a new class of chemokine. Science, 266, 1395-1399.
32. KURIHARA T., WARR G., LOY J. and BRAVO R. (1997): Defects in macrophage recruitment and host defense in mice lacking the CCR2 chemokine receptor. J. Exp. Med., 186, 1757-1762.
33. L'HEUREUX G. P., BOURGOIN S., JEAN N. MCCOLL S. R. and NACCACHE P. H. (1995): Diverging signal transduction pathways activated by interleukin-8 and related chemokines in human neutrophils: interleukin-8, but not NAP-2 or GRO alpha, stimulates phospholipase D activity. Blood, 85, 522-532.
34. LIAO F., ALKHATIB G., PEDEN K. W., SHARMA G., BERGER E. A. and FARBER J. M. (1997): STRL33, a novel chemokine receptor-like protein, functions as a fusion cofactor for both macrophage tropic and T cell line-tropic HIV-1. J Exp. Med., 185, 2015-2023.
35. LODI P. J., GARRETT D. S., KUSZEWSKI J., TSANG M. L., WEATHERBEE J. A., LEONARD W. J., GRONEMBORN A. M. and CLORE G. M. (1994): High-resolution solution structure of the β chemokine hMIP-1β by multidimensional NMR. Science, 263, 1762-1767.
36. LOETSCHER P. SEITZ, M., BAGGIOLINI M. and MOSER R B. (1996): Interleukin-2 regulates CC chemokine receptor expression and chemotactic responsiveness in T lymphocytes. J. Exp. Med., 184, 569-577.
37. LOWMAN H. B., SLAGLE P. H., DEFORGE L. E., WIRTH C. M., GILLECE-CASTRO B. L., BOURELL J. H. and FAIRBROTHER W. J. (1996): Exchanging interleukin-8 and melanoma growth-stimulating activity receptor binding specificities. J Biol. Chem., 271, 14344-14352.
38. MANTOVANI A., LOCATI M., ALLAVENA P. and SOZZANI S. (1996): The chemokine superfamily: crosstalk with the IL-1 system. Immunobiology, 195, 522-549.
39. MAYO K. H. (1991): Low-affinity platelet factor 4 1H NMR derived aggreagate equilibria indicate a physiologic preference for monomers over dimers and tetramers. Biochemistry, 30, 925-934.
40. MONTECLARO F. S., ARAI H. and CHARO I. F. (1997): Molecular approaches to identifying ligand binding and signaling domains of C-C chemokine receptors. Methods Enzymol., 288, 70-84.
41. MOORE J. P. and TRKOLA A. (1997): HIV type 1 coreceptors, neutralization serotypes, and vaccine development. AIDS Res. Hum. Retroviruses, 13, 733-736.
42. MUELLER S. G., SCHRAW W. P. and RICHMOND A. (1994): Melanoma growth stimulatory activity enhances the phosphorylation of the class II interleukin-8 receptor in nonhemopoietic cells. J. Biol. Chem., 269, 1973-1980.
43. MUELLER S. G., SCHRAW W. P. and RICHMOND A. (1995): Activation of protein kinase C enhances the phosphorylation of the type B interleukin-8 receptor and stimulates its degradation in non-hematopoietic cells. J. Biol. Chem., 270, 10439-10448.
44. MUELLER S. G., WHITE J. R., SCHRAW W. P., LAM V. and RICHMOND A. (1997): Ligand-induced desensitization of the human CXC chemokine receptor-2 is modulated by multiple serine residues in the carboxyl-terminal domain of the receptor. J. Biol. Chem., 272, 8207-8214.
45. MURPHY P. M. (1996): Chemokine receptors: structure, function and role in microbial pathogenesis. Cytokine Growth Factor Rev., 7, 47-64.
46. NAGASAWA T., HIROTA S., TACHIBANA K., TAKAKURA N., NISHIKAWA S., KITAMURA Y., YOSHIDA N., KIKUTANI H. and KISHIMOTO T. (1996): Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature, 382, 635-638.
47. OPPENHEIM J. J., WANG J. M., CHERTOV O., TAUB D. D. and BEN-BARUCH A. (1996): The role of chemokines in transplantation biology. In TILNEY, N. L., STROM T. B. and PAUL, L. C. (eds.): Cellular and molecular aspects. Lippincott-Raven Publisher. Philadelphia, 182-200.
48. PAN Y., LLOYD C., ZHOU H., DOLICH S., DEEDS J., GONZALO J. A., VATH J., GOSSELIN M., MA J., DUSSAULT B., WOOLF E., ALPERIN G., CULPEPPER J., GUTIERREZ-RAMOS J. C. and GEARING D. (1997): Neurotactin, a novel membrane-anchored chemokine that is upregulated in brain inflammation. Nature, 387, 611-617.
49. PAOLINI J. F., WILLARD D., CONSLER T., LUTHER M. and KRANGEL M. S. (1994): The chemokines IL-8, monocyte chemoattractant protein-1, and I-309 are monomers at physiologically relevant concentrations. J. Immunol., 153, 2704-2717.
50. PAXTON W. A., MARTIN S. R., TSE D., O'BRIEN T. R., SKURNICK J., VAN DEVANTER N. L., PADIAN N., BRAUN J. F., KOTLER D. P., WOLINSKY S. M. and KOUP R. A. (1996): Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposure. Nat. Med., 2, 412-417.
51. PLESKOFF O., TREBOUTE C., BRELOT A., HEVEKER N., SEMAN M. and ALIZON M. (1997): Identification of a chemokine receptor encoded by human cytomegalovirus as a cofactor for HIV-1 entry. Nature, 276, 1874-1878.
52. PREMACK B. A. and SCHALL T. J. (1996): Chemokine receptors: gateways to inflammation and infection. Nat. Med., 2, 1174-1178.
53. RAJARATHNAM K., SYKES B. D., KAY C. M., DEWALD B., GEISER T., BAGGIOLINI M. and CLARK-LEWIS I. (1994): Neutrophil activation by monomeric interleukin-8. Science, 264, 90-92.
54. ROLLINS B. J. (1997): Chemokines. Blood, 90, 909-928.
55. ROTHENBERG M. E., MACLEAN J. A., PEARLMAN E., LUSTER A. D. and LEDER P. (1997): Targeted disruption of the chemokine eotaxin partially reduces antigen-induced tissue eosinophilia. J. Exp. Med., 185, 785-790.
56. SALLUSTO F., MACKAY C. R. and LANZAVECCHIA A. (1997): Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science, 277, 2005-2007.
57. SOZZANI S., ALLAVENA P., VECCHI A. and MANTOVANI A. (1999): The role of chemokines in the regulation of dendritic cell trafficking. J. Leukoc. Biol., 66, 1-9.
58. SOZZANI S., LOCATI M., ZHOU D., RIEPPI M., LUINI W., LAMORTE G., BIANCHI G., POLENTARUTTI N., ALLAVENA P. and MANTOVANI A. (1995): Receptors, signal transduction, and spectrum of action of monocyte chemotactic protein-1 and related chemokines. J. Leukoc. Biol., 57, 788-794.
59. TAUB D. D. and OPPENHEIM J. J. (1994): Chemokines, inflammation and the immune system. Therap. Immunol., 1, 229-246.
60. UGUCCIONI M., D'APUZZO M., LOETSCHER M., DEWALD B. and BAGGIOLINI M. (1995): Actions of the chemotactic cytokines MCP-1, MCP-2, MCP-3, RANTES, MIP-1α and MIP-1β on human monocytes. Eur. J. Immunol., 25, 64-68.
61. WANG J. M., DENG X., GONG W. and SU S. B. (1998): Chemokines and their role in tumor growth and metastasis. J. Immunol. Methods, 220, 1-17.
62. WANG J. M. SU S. B., GONG W. and OPPENHEIM J. J. (1998): Chemokines, receptors, and their role in cardiovascular pathology. Int. J. Clin. Lab. Res., 28, 83-90.
63. WANG J. M., TARABORETTI G., MATSUSHIMA K., VAN DAMME J. and MANTOVANI A. (1990): IL-8 induces haptotaxis and chemotaxis of melanoma cells. Biochem. Biophys. Res. Commun., 169, 165-169.
64. WEBB L. M., EHRENGRUBER M. U., CLARK-LEWIS I., BAGGIOLINI M. and ROT A. (1993): Binding to heparan sulfate or heparin enhances neutrophil responses to interleukin 8. Proc. Natl. Acad. Sci. USA, 90, 7158-7162.
65. WILLIAMS G., BORKAKOTI N., BOTTOMLEY G. A., COWAN I., FALLOWFIELD A. G., JONES P. S., KIRTLAND S. J., PRICE G. J. and PRICE L. (1996): Mutagenesis studies of interleukin-8. Identification of second epitope involved in receptor binding. J. Biol. Chem., 271, 9579-9586.
66. WITT D. P. and LANDER A. D. (1994): Differential binding of chemokines to glycosaminoglycan subpopulations. Curr. Biol., 4, 392-400.
67. WONG L. M., MYERS SJ., TSOU C. L., GOSLING J., ARAI H. and CHARO I. F. (1997): Organization and differential expression of the human monocyte chemoattractant protein 1 receptor gene. Evidence for the role of the carboxyl-terminal tail in receptor trafficking. J. Biol. Chem., 272, 1038-1045.
68. YOSHIDA T., IMAI T., KAKIZAKI M., NISHIMURA M., TAKAGI S. and YOSHIE O. (1998): Identification of single C motif-1/lymphotactin receptor XCR1. J. Biol. Chem., 273, 16551-16554.
69. ZHANG Y. J., RUTLEDGE B. J. and ROLLINS B. J. (1994): Structure/activity analysis of human monocyte chemoattractant protein-1 (MCP-1) by mutagenesis: Identification of mutated protein that inhibits MCP-1-mediated monocyte chemotaxis. J. Biol. Chem., 266, 15918-15924.
70. ZHOU Y., KURIHARA T., RYSECK R. P., YANG Y., RYAN C., LOY J., WARR G. and BRAVO R. (1998): Impaired macrophage function and enhanced T cell-dependent immune response in mice lacking CCR5, the mouse homologue of the major HIV-1 coreceptor. J. Immunol., 160, 4018-4025.
71. ZLOTNIK A., MORALES J. and HEDRICK J. A. (1999): Recent advances in chemokines and chemokine receptors. Crit. Rev. Immunol., 19, 1-47.